1. Introduction {#s0005}
===============

With high-throughput production of gene and protein sequences, the rate of addition of new sequences to the databases increased exponentially. Such a collection of sequences does not, by itself, increase the scientist\'s understanding of the biology of organisms. However, comparing new sequences to those with known functions is a key way of understanding the biology of an organism.

Many methods have been proposed for sequence comparison. They can be categorized into two classes. One is alignment-based methods, in which dynamic programming is used to find an optimal alignment by assigning scores to different possible alignments and picking the alignment with the highest score. Several alignment-based algorithms have been proposed such as global alignment, local alignment, with or without overlap ([@bib9], [@bib22], [@bib31], [@bib28], [@bib29]). Waterman ([@bib35]) and Durbin et al. ([@bib5]) provided comprehensive reviews about this method. However, the search for optimal solutions using sequence alignment has problems in: (i) computationally load with large biological databases and (ii) choice of the scoring schemes ([@bib24], [@bib34]). Therefore, the emergence of research into the second class, alignment-free methods, is apparent and necessary to overcome critical limitations of alignment-based methods.

Up to now, many alignment-free methods have been proposed, but they are still in the early development compared with alignment-based methods. One of the most widely used alignment-free approaches is statistical model, in which each sequence is first mapped into an m-dimensional vector according to its k-word frequencies, and sequence similarity can then be measured by distance measures, such as Euclidean distance ([@bib3]), Pearson\'s correlation coefficient ([@bib8]), Kullback--Leibler discrepancy ([@bib37]), Cosine distance ([@bib33]) among their corresponding vectors. Recently, [@bib6] studied probabilistic properties of words in sequences, deducted the exact distributions and evaluated its asymptotic approximations. When the k-words occurring in biological sequence are estimative probabilities rather than frequencies, they are more easily described by more complex models such as Markov model ([@bib24], [@bib12], [@bib36], [@bib1]), mixed model ([@bib13]) and Bernoulli model ([@bib21]).

Graphical representation is another widely used alignment-free method. It provides a simple way to view, sort and compare various gene sequences with their intuitive pictures and pattern. Randic et al. gave a comprehensive review on these methods ([@bib26], [@bib27]). In order to facilitate comparison of different biological sequences, they transformed graphical representations into some mathematical objects such as E matrix ([@bib38], [@bib16], [@bib32]), D/D matrix([@bib14], [@bib38], [@bib16], [@bib32]), L/L matrix ([@bib25], [@bib14], [@bib38], [@bib16], [@bib32]) and their "high order" matrices ([@bib38], [@bib32]). Once a matrix was given, they calculated matrix invariants as descriptors of the sequence, such as the average matrix element, the average row sum, the leading eigen value and the Wiener number. But, for long sequences, these methods become less useful because they require complex repetitive computation to get matrix invariants.

Recently, Out and Sayood introduced Lempel--Ziv (LZ) complexity to compute the distance between two DNA sequences ([@bib23]). Because it is based on exact direct repeats, the LZ complexity works well with the small DNA alphabet. Unlike DNA sequences, protein sequences and RNA secondary structures consist of more complex alphabets and structure information, which poses more of a challenge for LZ complexity. So Bacha and Baurain, Liu and Wang, Chen and Zhang presented several strategies in which protein sequences or RNA secondary structures were encoded to a new alphabet prior to computation of the LZ complexity ([@bib2], [@bib18], [@bib41], [@bib39], [@bib4]). Zhang et al. found that the LZ complexity is strongly correlated with sequence length and proposed a normalized LZ complexity for sequence comparison ([@bib40]). Taking into account a specific kind of the inexact copy in the text, Li et al. generalized the LZ complexity and proposed a new sequence distance measure for sequence comparison ([@bib15]). Liu et al. introduced relative LZ complexity to depict the complexity relationship between two sequences ([@bib17]).

All above LZ-based methods have achieved promising results in biological sequence comparison, but they generally placed a heavy emphasis on the number of components in the exhaustive history, so little attention has been paid to the components themselves. In this paper, we used the proposed revised LZ complexity to obtain a series of LZ-words from the exhaustive history of biological sequences. Based on the LZ-word distributions, we constructed a sorted union LZ-word set from which an indicator sequence was obtained. We then calculated numerical characteristics of the indicator sequence to compare biological sequences. The performance of the proposed method was evaluated by the phylogenetic analysis and comparison with alignment-based method.

2. Method {#s0010}
=========

2.1. LZ-words of DNA sequences {#s0015}
------------------------------

Given a finite alphabet $\Omega$, let *U*, *V* and *W* be sequences over it. *L*(*U*) is the length of the sequence *U*, $U(i)$ is the *i*-th element of *U*, and $U(i, j)$ is the subsequence of *U* starting at position *i* and ending at position *j*. Here, $U(i, j) = \varnothing$, for $i > j$. Concatenating *V* and *W* can construct a new sequence *U*=*VW*, in this equation, *V* is named "a prefix" of *U*, and *U* is called "an extension" of *V* if there exists an integer *i* such that $V = U(1, i)$. An extension *U*=*VW* of *V* is reproducible from *V* denoted by $\left. V\rightarrow U \right.$, if there exists an integer $P \leq L(V)$ such that $W(k) = U(p + k - 1)$, for *k*=1, 2,*...*, *L*(*W*). A non-null sequence *U* is producible from its prefix $U(1, j)$, denoted by $\left. U(1, j)\Rightarrow U \right.$, if $\left. U(1, j)\rightarrow U(1, L(U) - 1) \right.$. For example: $\left. 01\Rightarrow 0100 \right.$ with *p*=1. Note that, the producibility allows for an extra different symbol at the end.

Usually, a DNA primary sequence can be taken as a string of letters A, G, C, and T, which denote the four nucleic acid bases: adenine, guanine, cytosine, and thymine, respectively. Let $S = s_{1}s_{2}...s_{n}$ to be a DNA sequence. To indicate a substring of *S* that starts at position *i* and ends at position *j*, we write $S(i, j)$, where is, $S(i, j) = s_{i}s_{i + 1}...s_{j}$ for $i \leq j$. Any sequence *S* can be built using a production process where at its *i*th step $\left. S(1, h_{i - 1})\Rightarrow S(1, h_{i}) \right.$, which is described as following:(1)At the beginning, we had a null-sequence, denoted by $\varnothing$. We then added a prefix$s_{1}$ to $\varnothing$ and obtained a new sequence *S*. If $L(S) > 1$, we added a symbol "$\ast$"after $S(1, 1)$.(2)Let a prefix $Q = S(1, h_{1}) \ast S(h_{1} + 1, h_{2}) \ast \cdots \ast S(h_{m - 1} + 1, h_{m})$, checked if $R = S(h_{m},h_{m} + 1)$ can be reproduced from the sequence $Q = S(1, h_{m})$. If $R$ could not be reproduced from the set, then joined *Q* and *R* to get a new prefix *QR*, and added a symbol "$\ast$"following *QR*. If *R* could be reproduced from the set, then checked again if $R = S(h_{m},h_{m} + 2)$ can reproduced from the sequence $Q = S(1, h_{m})$. If so, checked again if $R = S(h_{m},h_{m} + 3)$ can reproduced from the sequence $Q = S(1, h_{m})$, $\cdots$ and so on. There two possible cases: in the case $R = S(h_{m},L(S))$, we ended the procedure and got new prefix $QR = S$; in another case $R = S(h_{m},h_{m + 1})$ cannot be reproduced from the sequence$Q = S(1, h_{m})$, we got a new prefix *QR* and added a symbol"$\ast$" behind it.(3)Repeated the step (2) until produce *S*.

Instead of focusing on the total number of components in the exhaustive history, we analyzed the components themselves. For convenience, we denoted a component in the exhaustive history as a LZ-word, and all the components in the exhaustive history as a LZ-word set. For example, the LZ-words of *S*=ATGGTCGGTTTC can be gotten through the following steps, where $\ast$ is used to separate the decomposition component:•Generate a novel symbol **A**: Ø+A→A.•Generate a novel symbol **T**: A+T→AT.•Generate a novel symbol **G**: A$\ast$T+G→A$\ast$T$\ast$G.•Copy the longest fragment+generate a additional symbol G**T**: A$\ast$T$\ast$G+GT→A$\ast$T$\ast$G$\ast$GT.•Generate a novel symbol **C**: A$\ast$T$\ast$G$\ast$GT+C→A$\ast$T$\ast$G$\ast$GT$\ast$C.•Copy the longest fragment+generate a additional symbol GGTT: A$\ast$T$\ast$G$\ast$GT$\ast$C→A$\ast$T$\ast$G$\ast$GT$\ast$C$\ast$GGTT.•Copy the longest fragment T**C**: A$\ast$T$\ast$G$\ast$GT$\ast$C$\ast$GG$\ast$TT→A$\ast$T$\ast$G$\ast$GT$\ast$C$\ast$ GG$\ast$TT$\ast$TC.

A, T, G, GT, C, GGTT and TC are the LZ-words of the sequence *S*. And {A, T, G, GT, C, GGTT, TC} is the LZ-word set of the sequence *S.*

2.2. Revised LZ-words of DNA sequences {#s0020}
--------------------------------------

LZ complexity of a sequence is measured by the minimal number of steps required for its synthesis in a certain process. For each step only two operations are allowed in the process: either generating an additional symbol which ensures the uniqueness of each component or copying the longest fragment from the part of a synthesized sequence. When a new decomposition component $S(1, h_{i})$ is generated, it should be checked whether it is copied from the longest fragment of the $S(1, h_{i - 1})$. Consequently, the length of LZ-word inevitably becomes large as production process going on. With this problem in mind, we proposed a revised LZ complexity that is described as following:(4)At the beginning, we had a null-sequence, denoted by$\varnothing$. We then added a prefix $s_{1}$ to $\varnothing$ and obtained a new sequence *S*. If $L(S) > 1$, we added a symbol"$\ast$"after $S(1, 1)$.(5)Let a prefix $Q = S(1, h_{1}) \ast S(h_{1} + 1, h_{2}) \ast \cdots \ast S(h_{m - 1} + 1, h_{m})$, checked if $R = S(h_{m},h_{m} + 1)$ can be reproduced from the set$\left\{ S(1, h_{1}), S(h_{1} + 1, h_{2}),\cdots,S(h_{m - 1} + 1, h_{m}) \right\}$. If $R$ could not be reproduced from the set, then joined *Q* and *R* to get a new prefix *QR*, and added a symbol"$\ast$"following *QR*. If *R* could be reproduced from the set, then checked again if $R = S(h_{m},h_{m} + 2)$can reproduced from the set$\left\{ S(1, h_{1}),S(h_{1} + 1, h_{2}),\cdots,S(h_{m - 1} + 1, h_{m}) \right\}$. If so, checked again if $R = S(h_{m},h_{m} + 3)$ can reproduced from the set$\left\{ S(1, h_{1}),S(h_{1} + 1, h_{2}),\cdots,S(h_{m - 1} + 1, h_{m}) \right\}$, $\cdots$ and so on. There two possible cases: in the case $R = S(h_{m},L(S))$, we ended the procedure and got new prefix $QR = S$; in another case $R = S(h_{m},h_{m + 1})$ cannot be reproduced from the set $\left\{ S(1, h_{1}), S(h_{1} + 1, h_{2}),\cdots,S(h_{m - 1} + 1, h_{m}) \right\}$, we got a new prefix *QR* and added a symbol "$\ast$" behind it.(6)Repeated the step (2) until produce *S*.Take the above sequence *S*=ATGGTCGGTTTC as an example, we obtained its revised LZ-words through the following steps, where $\ast$ is used to separate the decomposition component: •Generate a novel symbol **A**: Ø+A→A.•Generate a novel symbol **T**: A+T→AT.•Generate a novel symbol **G**: A$\ast$T+G→A$\ast$T$\ast$G.•Copy the fragment G+ generate a additional symbol **T**: A$\ast$T$\ast$G+GT→A$\ast$T$\ast$G$\ast$GT.•Generate a novel symbol **C**: A$\ast$T$\ast$G$\ast$GT+C→A$\ast$T$\ast$G$\ast$GT$\ast$C.•Copy the fragment G+generate a additional symbol **G**: A$\ast$T$\ast$G$\ast$GT$\ast$C→A$\ast$T$\ast$G$\ast$GT$\ast$C$\ast$GG.•Copy the fragment T+generate a additional symbol **T**: A$\ast$T$\ast$G$\ast$GT$\ast$C→A$\ast$T$\ast$G$\ast$GT$\ast$C$\ast$GG⁎TT.•Copy the fragment T+generate a additional symbol **C**: A$\ast$T$\ast$G$\ast$GT$\ast$C$\ast$GG$\ast$TT→A$\ast$T$\ast$G$\ast$GT$\ast$C$\ast$ GG$\ast$ TT$\ast$TC.

A, T, G, GT, C, GG, TT and TC are revised LZ-words of the sequence *S*. And {A, T, G, GT, C, GG, TT, TC} is revised LZ-word set of the sequence *S*. It is interesting to note that the maximum length of the revised LZ-word set is 2, significantly smaller than that of the LZ-word set.

2.3. Operation measure between different revised LZ-word sets {#s0025}
-------------------------------------------------------------

Given a DNA sequence, we can get a revised LZ-word set. Here, we are interested not only in using the revised LZ-word set to numerically characterize the biological sequences, but also in facilitating comparison of biological sequences.

There is a large body of literatures on word statistics, where a sequence is interpreted as a succession of symbols ([@bib30]). A *k*-word is a series of *k* consecutive letters in a sequence. The word statistical analysis consists of counting occurrences of words and calculating their numerical characteristics. The standard approach for counting *k*-words in a sequence of length *m* is to use a sliding window of length *k*, shifting the frame one base at a time from position1 to *m-k+1*. Instead of counting the LZ-words\' content, we analyzed the distribution diversity of revised LZ-words and designed an operation measure to compare biological sequences.

Given two DNA sequences *X* and *Y*, we obtained their revised LZ-word sets $RLZSet_{X}$ and $RLZSet_{Y}$. We then blended $RLZSet_{X}$ and $RLZSet_{Y}$ to compose anther set $RLZSet_{X - Y}$ $$RLZSet_{X - Y} = RLZSet_{X} \oplus RLZSet_{Y}.$$According to the length of revised LZ-words, the $RLZSet_{X - Y}$ set is divided into several mutually exclusive sets $RLZSet_{X - Y}^{t}$ $$RLZSet_{X - Y} = \underset{t}{\cup}{RLZSet_{X - Y}^{t}},$$where$$RLZSet_{X - Y}^{t} = \left\{ x \in RLZset_{X - y} \middle| length(x) = t \right\}.$$We then lined the elements of the $RLZSet_{X - Y}^{t}$ set in the lexicographic order and got an ordered $\left. \uparrow RLZSet_{X - Y} \right.$ set$$\left. \uparrow RLZSet_{X - Y} = \left\{ \uparrow RLZSet_{X - Y}^{1},\uparrow RLZSet_{X - Y}^{2},\uparrow RLZSet_{X - Y}^{3},\cdots \right\}. \right.$$For example, if *X=ATGCGTCGGTCCACCCACGTA* and *Y=ATCGGTCTGTTACAGACTACG* are two given DNA sequences, we can get there $\left. \uparrow RLZSet_{X} \right.$, $\left. \uparrow RLZSet_{X} \right.$ and $\left. \uparrow RLZSet_{X - Y} \right.$ sets:$\left. \uparrow RLZSet_{X} \right.$={A, C, G, T, CA, CC, CT, GT, CAC, GTA, GTC},$\left. \uparrow RLZSet_{Y} \right.$={A, C, G, T, AC, AG, CT, GT, ACT, GTC, GTT},$\left. \uparrow RLZSet_{X - Y} \right.$={A, A, C, C, G, G, T, T, AC, AG, CA, CC, CT, CT, GT, GT, ACT, CAC, GTA, GTC, GTC, GTT}.

Now we focus on the blend degree of two biological sequences. Given any pair of neighboring elements in $\left. \uparrow RLZSet_{X - Y} \right.$ set, there are two possible cases: if one is from $RLZSet_{X}$($RLZSet_{X}$) and the other is from $RLZSet_{Y}$($RLZSet_{X}$), we suppose there is transition operation (![](fx1.gif)) between them. Otherwise, they may both come from the same set $RLZSet_{X}$($RLZSet_{Y}$), we suppose there is extension operation (---) between them. Take above two sequences *X* and *Y* for an example, we first listed all the elements of the $\left. \uparrow RLZSet_{X}^{t} \right.$ sets in a line with "$\bullet$" denoting them, and list all the elements of the$\left. \uparrow RLZSet_{Y}^{t} \right.$ sets in a line with "$\circ$" denoting them. We then presented all the operations between the $\left. \uparrow RLZSet_{X}^{t} \right.$ sets and the $\left. \uparrow RLZSet_{Y}^{t} \right.$ sets based on the$\left. \uparrow RLZSet_{X - Y} \right.$ set, which is shown in [Fig. 1](#f0005){ref-type="fig"}.Fig. 1All the transition operations and extension operations between the $\left. \uparrow RLZSet_{X}^{t} \right.$ sets and the $\left. \uparrow RLZSet_{Y}^{t} \right.$ sets according to the $\left. \uparrow RLZSet_{X - Y} \right.$ set.

It is interesting to note that the transition operations in the operation figure indicate the similarity between the $\left. \uparrow RLZSet_{X}^{t} \right.$ sets and the $\left. \uparrow RLZSet_{Y}^{t} \right.$ set, and the extension operations imply their diversity. That is to say, the more the extension operations are, the more similar the $\left. \uparrow RLZSet_{X}^{t} \right.$ sets and the $\left. \uparrow RLZSet_{Y}^{t} \right.$ set are. According to that, we define length of the operations $L(O)$ as follows:$$L(O) = \left\{ \begin{matrix}
{1,if operation is transition} \\
{ t + 1, if t consecutiveoperations are extensition} \\
\end{matrix} \right.$$

Given an operation $L(O)$ with length$\xi$, we counted its total appearances ($N_{L(o) = \xi}$) in operation figure. Since $L(O)$ varies with different value$\zeta$, it can be regarded as a discrete random variable. Given a random variable$L(O)$, and a positive integer $n$, $P(L(O) = n)$ is the probability that $L(O)$takes the value $n$ $$P(L(O) = n) = N_{L(o) = n}/{\sum\limits_{\xi}N_{L(o) = \xi}}$$The collection of pairs$(P(L(O) = n), n)$, for all positive integer $n$, is the probability distribution of the listed as follows:*L*(*O*)*L*(*O*)=1*L*(*O*)=2...*L*(*O*)=n...*PP*(*L*(*O*)=1)*P*(*L*(*O*)=2)...*P*(*L*(*O*)=n)...Take all the operations in [Fig. 1](#f0005){ref-type="fig"} for an example, the probability distribution of the operations is$L(O)$$L(O) = 1$$L(O) = 2$$L(O) = 3$*P*11/152/152/15Based on the operation distribution function, we calculated its expectation and propose an operation measure ($OMeasure$) between two sequence X and Y,$$OMeasure(X,Y) = {\sum\limits_{z \geq 1}{z \times P(L(O) = z)}} - 1.$$ $OMeasure$, the average length of the operation, is depended on both the extension operations and transition operations. It is important to note that $OMeasure$ only satisfies the identity and symmetry, it does not satisfy inequality conditions. So it is only a dissimilarity measure for sequence comparison.

We are interested in $OMeasure$ for two reasons. First of all, it provides an opportunity to study the components\' distribution which is, in some ways, more singular than the total number of components in the exhaustive history. The second reason involves the lengths of the operations because differencing lengths of the operations strengthens the effects of the different operations.

3. Results and discussion {#s0030}
=========================

3.1. Comparison of component distribution in the exhaustive history between Lempel--Ziv (LZ) complexity and revised Lempel--Ziv complexity {#s0035}
------------------------------------------------------------------------------------------------------------------------------------------

One of the characteristics of the revised Lempel--Ziv complexity is to check whether$R = S(h_{m},h_{m + 1} - 1)$can be reproduced from the set $\left\{ S(1, h_{1}), S(h_{1} + 1, h_{2}),\cdots,S(h_{m - 1} + 1, h_{m}) \right\}$ instead of from the set $S(1, h_{m})$. To find their difference, we compared their LZ-word\'s distributions.

We first compared their component difference in the exhaustive histories. For example, HCoV-229E is a given sequence of Human coronavirus, its length is 27,317 with accession number [NC_002645](ncbi-n:NC_002645){#ir0365}. With Lempel--Ziv complexity and revised Lempel--Ziv complexity, we got two exhaustive histories.

We then deleted all the symbols "$\ast$" in the exhaustive histories and obtained two new deduced sequences HCoV-229E_LZ and HCoV-229E_RLZ. It is difficult for us to observe sequence difference directly, but we can calculate *k*-word counts of the deduced sequences to assess their difference. [Fig. 2](#f0010){ref-type="fig"} is the *k*-word counts of the deduced sequences HCoV-229E_LZ and HCoV-229E_RLZ with *k* from 1 to 4. Interestingly, the *k*-word counts of the deduced sequences HCoV-229E_LZ and HCoV-229E_RLZ are similar in [Fig. 2](#f0010){ref-type="fig"}. That is to say, the sequence information held through Lempel--Ziv (LZ) complexity and revised Lempel--Ziv complexity operation is similar.Fig. 2The comparison of k-word counts of the deduced sequences HCoV-229E_LZ and HCoV-229E_RLZ with k from 1 to 4.

In statistics, one-way analysis of variance (abbreviated one-way ANOVA) is a technique used to compare means of two or more samples (using the F distribution). Here, we used a one-way ANOVA to test whether the *k*-word counts of the deduced sequences HCoV-229E_LZ and HCoV-229E_RLZ differ from each other. The F value obtained by one-way ANOVA test tells us whether the data is significantly different from the Gaussian distribution or not. We rejected the hypothesis if the test is significant at the 0.05 level. Since the F-value is 0.91\>F~0.05~, there is no significant difference between the *k*-word counts of the deduced sequences HCoV-229E_LZ and HCoV-229E_RLZ. That is to say, the components in the exhaustive history between Lempel--Ziv complexity and revised Lempel--Ziv complexity are similar.

We found that the total number of components in the exhaustive history with the revised Lempel--Ziv (LZ) complexity algorithm is 4491, which is 1026 larger than Lempel--Ziv (LZ) complexity algorithm. In addition to components\' distribution in the exhaustive history, we also compared the distribution of lengths of the components in the exhaustive history. Take the HCoV-229E as an example, [Fig. 3](#f0015){ref-type="fig"} is the comparison of length distribution of the components in the exhaustive history obtained by Lempel--Ziv complexity and revised Lempel--Ziv complexity. It is interesting to note that there is a great difference between the lengths of the components in the exhaustive history. The maximum length of the components obtained by Lempel--Ziv complexity is 16, while that of the components obtained by revised Lempel--Ziv complexity is only 10. The most appearance length of the components obtained by revised Lempel--Ziv complexity is 6, which is 2 smaller than that of the components obtained by Lempel--Ziv complexity.Fig. 3Comparison of length distribution of the components in the exhaustive history obtained by Lempel--Ziv (LZ) complexity and revised Lempel--Ziv complexity.

Comparison between Lempel--Ziv (LZ) complexity and revised Lempel--Ziv complexity illustrates that they can both extract the similar information of the primary sequences, but the component lengths in the exhaustive history obtained by the revised Lempel--Ziv complexity are obviously smaller than Lempel--Ziv complexity. So the revised Lempel--Ziv complexity is a better way to make the components easier to handle.

3.2. Influence of set splitting methods on operation measure {#s0040}
------------------------------------------------------------

Given two DNA sequences *X* and *Y*, we obtained their revised LZ-word sets $RLZSet_{X}$ and $RLZSet_{Y}$ with the revised Lempel--Ziv complexity. We then blended $RLZSet_{X}$ and $RLZSet_{Y}$ to compose anther set $RLZSet_{X - Y}$. In order to highlight the influence of different LZ-words\' size, we divided the $RLZSet_{X - Y}$set into several mutually exclusive sets $RLZSet_{X - Y}^{t}$ according to the length of revised LZ-word *t*. It is worthy to note that mutually exclusive sets $RLZSet_{X - Y}^{t}$ rely heavily on set splitting methods. In order to evaluate the influence of the set splitting methods, we adopted the operation measure to classify HEV Genotypes with step-wise refinement of set splitting methods.

HEV (Hepatitis E virus) is a non-enveloped, positive-sense, single-stranded RNA virus and belongs to Hepevirus genus under the separate family of Hepeviridea ([@bib20]). The genome of HEV is approximately 7.2 kb in length and contains a short 5′ untranslated region (5′ UTR), three overlapped open reading frames (ORF1, ORF2, and ORF3′) and a short 3′ UTR. We retrieved a total of 48 full-length HEV genome sequences from NCBI (<http://www.ncbi.nlm.nih.gov/>). Abbreviation for the strains, accession number, nucleotide length, country, and genotype of all HEV genomes ([@bib20]) are described in [Table 1](#t0005){ref-type="table"}. And the 48 HEV genomes were distinctly clustered into four genotypes by the traditional classification ([@bib19]).Table 1Abbreviation for the strains, accession number, nucleotide length, genotype, acronym and country for each of the 48 complete HEV genomes.**NoStrain nameAccessionLengthGenotypeAbbreviationCountry**1B1 (Bur-82)[M73218](ncbi-n:M73218){#ir0005}7207IAABurma (Rangoon)2B2 (Bur-86)[D10330](ncbi-n:D10330){#ir0010}7194IABBurma (Rangoon)3I2 \[Mad-93\][X99441](ncbi-n:X99441){#ir0015}7194IACIndia (Madras)4I3[AF076239](ncbi-n:AF076239){#ir0020}7194IADIndia (Hyderabad)5Np1(TK15/92)[AF051830](ncbi-n:AF051830){#ir0025}7199IAENepal (Kathamandu)6P2\[Abb-2B\][AF185822](ncbi-n:AF185822){#ir0030}7143IAFPakistan (Abbottabad)7Yam-67[AF459438](ncbi-n:AF459438){#ir0035}7206IAGIndia (Yamuna Nagar)8C1(CHT-88)[D11092](ncbi-n:D11092){#ir0040}7207IAHChina (Xinjiang, Hetian)9C2(KS2--87)[L25595](ncbi-n:L25595){#ir0045}7221IAIChina (Xinjiang, Kashi)10C3(CHT-87)[L08816](ncbi-n:L08816){#ir0050}7176IAJChina (Xinjiang, Hetian)11C4(Uigh179)[D11093](ncbi-n:D11093){#ir0055}7194IAKChina (Xinjiang, Uighur)12China Hebei[M94177](ncbi-n:M94177){#ir0060}7200IARChina (Hebei)13P1(Sar-55)[M80581](ncbi-n:M80581){#ir0065}7138IAMPakistan (Sargodha)14I1(FHF)[X98292](ncbi-n:X98292){#ir0070}7202IANIndia15Morocco[AY230202](ncbi-n:AY230202){#ir0075}7212IAOMorocco16T3[AY204877](ncbi-n:AY204877){#ir0080}7170IAPChad17M1[M74506](ncbi-n:M74506){#ir0085}7180IIBBMexico (Telixtac)18HE-JA10[AB089824](ncbi-n:AB089824){#ir0090}7262IIICAJapan (Tokyo)19JKN-Sap[AB074918](ncbi-n:AB074918){#ir0095}7256IIICBJapan (Sapporo)20JMY-HAW[AB074920](ncbi-n:AB074920){#ir0100}7240IIICCJapan (Sapporo)21swUS1[AF082843](ncbi-n:AF082843){#ir0105}7207IIICDUSA22US1[AF060668](ncbi-n:AF060668){#ir0110}7202IIICEUSA (Minnesota)23US2[AF060669](ncbi-n:AF060669){#ir0115}7277IIICFUSA (Tennessee)24JBOAR1-Hyo04[AB189070](ncbi-n:AB189070){#ir0120}7247IIICGJapan (Hyogo)25JDEER-Hyo03L[AB189071](ncbi-n:AB189071){#ir0125}7230IIICHJapan (Hyogo)26JJT-KAN[AB091394](ncbi-n:AB091394){#ir0130}7218IIICIJapan (Kanagawa)27JMO-Hyo03L[AB189072](ncbi-n:AB189072){#ir0135}7180IIICJJapan (Hyogo)28JRA1[AP003430](ncbi-n:AP003430){#ir0140}7230IIICKJapan (Tokyo)29JSO-Hyo03L[AB189073](ncbi-n:AB189073){#ir0145}7180IIICRJapan (Tokyo)30JTH-Hyo03L[AB189074](ncbi-n:AB189074){#ir0150}7180IIICMJapan (Tokyo)31JYO-Hyo03L[AB189075](ncbi-n:AB189075){#ir0155}7180IIICNJapan (Tokyo)32swJ570[AB073912](ncbi-n:AB073912){#ir0160}7257IIICOJapan (Tochigi)33Kyrgyz[AF455784](ncbi-n:AF455784){#ir0165}7239IIICPKyrgyzstan34Arkell[AY115488](ncbi-n:AY115488){#ir0170}7255IIICQCanada (Ontario, Guelph)35HE-JA1[AB097812](ncbi-n:AB097812){#ir0175}7258IVDAJapan (Hokkaido)36HE-JK4[AB099347](ncbi-n:AB099347){#ir0180}7250IVDBJapan (Tochigi)37HE-JI4[AB080575](ncbi-n:AB080575){#ir0185}7186IVDCJapan (Tochigi)38JAK-Sai[AB074915](ncbi-n:AB074915){#ir0190}7236IVDDJapan (Saitama)39JKK-Sap[AB074917](ncbi-n:AB074917){#ir0195}7235IVDEJapan (Sapporo)40JSM-Sap95[AB161717](ncbi-n:AB161717){#ir0200}7202IVDFJapan (Hokkaido)41JSN-Sap-FH[AB091395](ncbi-n:AB091395){#ir0205}7234IVDGJapan (Hokkaido)42JSN-Sap-FH02C[AB200239](ncbi-n:AB200239){#ir0210}7251IVDHJapan (Hokkaido)43JTS-Sap02[AB161718](ncbi-n:AB161718){#ir0215}7202IVDIJapan (Hokkaido)44JYW-Sap02[AB161719](ncbi-n:AB161719){#ir0220}7202IVDJJapan (Hokkaido)45swJ13--1[AB097811](ncbi-n:AB097811){#ir0225}7258IVDKJapan (Hokkaido)46swCH25[AY594199](ncbi-n:AY594199){#ir0230}7270IVDRChina (Uighur)47T1[AJ272108](ncbi-n:AJ272108){#ir0235}7232IVDMChina (Beijing)48CCC220[AB108537](ncbi-n:AB108537){#ir0240}7193IVDNChina (Changchun)

This experiment aims at assessing how well the operation measure with step-wise refinement of set splitting methods performs on classification. Here, set splitting methods with the step-wise refinement (SSM) are:$$\begin{array}{l}
{SSM_{1} = RLZSet_{X - Y}, SSM_{2} = RLZSet_{X - Y}^{1} \cup RLZSet_{X - Y}^{t \geq 2}, SSM_{3} = RLZSet_{X - Y}^{1} \cup RLZSet_{X - Y}^{2 - 4} \cup} \\
{RLZSet_{X - Y}^{t \geq 5}, SSM_{4} = RLZSet_{X - Y}^{1} \cup RLZSet_{X - Y}^{2 - 3} \cup RLZSet_{X - Y}^{4 - 5} \cup RLZSet_{X - Y}^{6 - 7} \cup RLZSet_{X - Y}^{t \geq 8},} \\
{SSM_{5} = \underset{t = 1}{\overset{9}{\cup}}{RLZSet_{X - Y}^{t}}.} \\
\end{array}$$In relation to the clustering literature ([@bib11]), Neighbor-joining ([@bib7]), a classic tree construction algorithm, can be considered as hierarchical methods. These results are represented in [Fig. 4](#f0020){ref-type="fig"}.Fig. 4Cluster trees of 48 HEV genomes using tree construction algorithm Neighbor-joining based on the proposed operation measure with *SSM*~1~, *SSM*~2~, *SSM*~3~, *SSM*~4~, and *SSM*~5~.

To evaluate the performance of the operation measure for HEV genotypes classification, we counted the number of misplaced HEV genotype against a gold standard. For the classification of HEV genotypes, we took the traditional classification as the gold standard ([@bib20]). The numbers of misplaced HEV genotype for the operation measure with *SSM* ~1~, *SSM* ~2~, *SSM* ~3~, *SSM* ~4~, and *SSM* ~5~ are 1, 1, 2, 1 and 0, respectively. These results indicate that the higher the refinement scheme is, the higher the operation measure efficiency is.

3.3. Phylogenetic analysis of coronaviruses {#s0045}
-------------------------------------------

Since the outbreak of atypical pneumonia referred to as severe acute respiratory syndrome (SARS), more attentions have been paid to the relationships between the SARS-CoVs and the other coronaviruses, which would be helpful to discover drugs and develop vaccines against the virus. Generally, coronaviruses can be divided into three groups according to serotypes. Group I and group II contain mammalian viruses, while group II coronaviruses contain a hemagglutinin esterase gene homologous to that of Influenza C virus. Group III contains only avian.

Based on the operation measure, we next considered to infer the phylogenetic relationships of coronaviruses with the complete coronavirus genomes. The 24 complete coronavirus genomes used in this article were downloaded from GenBank, of which 12 are SARS-CoVs and 12 are from other groups of coronaviruses. The name, accession number, abbreviation, and genome length for the 24 genomes are listed in [Table 2](#t0010){ref-type="table"}. Given a set of biological sequences, their phylogenetic relationship can be obtained through the following main operations: firstly, we construct the LZ-word set with revised Lempel--Ziv complexity and calculate the similarity/dissimilarity using operation measure; secondly, by arranging all the similarity/dissimilarity into a matrix, we obtain a pair-wise matrix; finally, we put the pair-wise distance matrix into the Unweighted Pair Group Method with Arithmetic Mean (UPGMA) program in the PHYLIP package ([@bib7]). [Fig. 5](#f0025){ref-type="fig"}(a) is phylogenetic tree of the 24 coronavirus genomes obtained using the proposed operation measure with *SSM* ~5~.Table 2The accession number, abbreviation, name and length for each of the 24 coronavirus genomes.NoAccessionGroupAbbreviationGenomeLength(nt)1[NC_002645](ncbi-n:NC_002645){#ir0245}IHCoV-229EHuman coronavirus 229E27,3172[NC_002306](ncbi-n:NC_002306){#ir0250}ITGEVTransmissible gastroenteritis virus28,5863[NC_002436](ncbi-n:NC_002436){#ir0255}IPEDVPorcine epidemic diarrhea virus28,0334[U00735](ncbi-n:U00735){#ir0260}IIBCoVMBovine coronavirus strain Mebus31,0325[AF391542](ncbi-n:AF391542){#ir0265}IIBCoVLBovine coronavirus isolate BCoV--LUN31,0286[AF220295](ncbi-n:AF220295){#ir0270}IIBCoVQBovine coronavirus strain Quebec31,1007[NC_003045](ncbi-n:NC_003045){#ir0275}IIBCoVBovine coronavirus31,0288[AF208067](ncbi-n:AF208067){#ir0280}IIMHVMMurine hepatitis virus strain ML--1031,1009[AF201929](ncbi-n:AF201929){#ir0285}IIMHV2Murine hepatitis virus stain 231,02810[AF208066](ncbi-n:AF208066){#ir0290}IIMHVPMurine hepatitis virus strain Penn 97--131,23311[NC_001846](ncbi-n:NC_001846){#ir0295}IIMHVMurine hepatitis virus31,27612[NC_001451](ncbi-n:NC_001451){#ir0300}IIIIBVAvian infectious bronchitis virus27,60813[AY278488](ncbi-n:AY278488){#ir0305}IVBJ01SARS coronavirus BJ0129,72514[AY278741](ncbi-n:AY278741){#ir0310}IVUrbaniSARS coronavirus Urbani29,72715[AY278491](ncbi-n:AY278491){#ir0315}IVHKU-39849SARS coronavirus HKU-3984929,74216[AY278554](ncbi-n:AY278554){#ir0320}IVCUHK-W1SARS coronavirus CUHK--W129,73617[AY282752](ncbi-n:AY282752){#ir0325}IVCUHK-Su10SARS coronavirus CUHK--Su1029,73618[AY283794](ncbi-n:AY283794){#ir0330}IVSIN2500SARS coronavirus Sin250029,71119[AY283795](ncbi-n:AY283795){#ir0335}IVSIN2677SARS coronavirus Sin267729,70520[AY283796](ncbi-n:AY283796){#ir0340}IVSIN2679SARS coronavirus Sin267929,71121[AY283797](ncbi-n:AY283797){#ir0345}IVSIN2748SARS coronavirus Sin274829,70622[AY283798](ncbi-n:AY283798){#ir0350}IVSIN2774SARS coronavirus Sin277429,71123[AY291451](ncbi-n:AY291451){#ir0355}IVTW1SARS coronavirus TW129,72924[NC_004718](ncbi-n:NC_004718){#ir0360}IVTOR2SARS coronavirus29,751Fig. 5Phylogenetic tree of 24 coronavirus genomes based on (a) the proposed operation measure and (b) multiple alignment CLUSTAL X.

Generally, an independent method can be developed to evaluate the accuracy of a phylogenetic tree, or the validity of a phylogenetic tree can be tested by comparing it with authoritative ones. Here, we adopted the form one to test the validity of our phylogenetic tree. Both two data sets were aligned with the multiple alignment CLUSTAL X and constructed the phylogenetic tree presented in [Fig. 5](#f0025){ref-type="fig"}(b).

[Fig. 5](#f0025){ref-type="fig"}(a) shows that our results are quite consistent with the authoritative results ([@bib10], [@bib42]) and that of the multiple alignment [Fig. 5](#f0025){ref-type="fig"}(b) in the following aspects. First of all, all SARS-CoVs are grouped in a separate branch, which appear different from the other three groups of coronaviruses. Secondly, BCOV, BCOVL, BCOVM, BCOVQ, MHV, MHV2, MHVM, and MHVP are grouped into a branch, which is consonant with the fact that they belong to group II. Thirdly, HCoV-229E, TGEV, and PEDV are closely related to each other, which is consistent with the fact that they belong to group I. Finally, IBV forms a distinct branch within the genus Coronavirus, because it belongs to group III. Rota et al. ([@bib43]) found out that the overall level of similarity between SARS-CoVs and the other coronaviruses is low. Our tree also reconfirms that SARS-CoVs are not closely related to any previously isolated coronaviruses and form a new group, which indicates that the SARS-CoVs have undergone an independent evolution path after the divergence from the other coronaviruses.

4. Conclusion {#s0050}
=============

Sequence comparison is one of the major goals of sequence analysis, which could serve as evidence of structural and functional conservation, as well as of evolutionary relations among the sequences. Despite the prevalence of the alignment-based methods, it is also noteworthy that it is computationally intensive and consequently unpractical for querying large data sets. Therefore, considerable efforts have been made to seek for alternative methods for sequence comparison.

This work presented a novel method to compare biological sequence with the revised Lempel--Ziv complexity. Instead of focusing on the total number of components in the exhaustive history, we analyzed the distribution of components themselves. Then we defined transition and extension operations among the revised LZ-word sets and represented them in the operation figure. With the length of operations in mind, we designed an operation measure to estimate the similarity/dissimilarity of two biological sequences. To assess the effectiveness of the proposed method, two sets of evaluation experiments were taken, and its performance was further compared with alignment-based methods. The results demonstrate that the proposed method is efficient, which highlight the necessity for LZ-based method to consider the whole distribution of the components in the exhaustive history. Thus, this understanding can then be used to guide development of more powerful alignment-free for biological sequence comparison.
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